Published by Josh White on 8th February 2022
(Sharecast News) - Predictive genetics technology company GENinCode announced on Tuesday the successful completion of its NHS clinical study, and positive results for its 'Lipid inCode' test for high cholesterol, including familial hypercholesterolemia (FH), undertaken at Royal Brompton and Harefield Hospitals.